B-FLEXION Life Sciences to acquire the remaining 57% stake in Radius Health from Patient Square Capital and Webster Equity Partners.

B-FLEXION Life Sciences, an investment manager, agreed to acquire the remaining 57% stake in Radius Health, a specialty biopharmaceutical company dedicated to bone health and related therapeutic area, from private equity firms Patient Square Capital and Webster Equity Partners. Financial terms were not disclosed. "We are extremely proud of the momentum of what has become a strong, profitable business within our portfolio. The team has built incredible commercial capabilities, and we look forward to continuing the success of TYMLOS® as it provides meaningful impact to the patients and families we serve," Nithya Desikan, B-FLEXION Life Sciences Operating Partner.